[Alternative Names]:IPH-2201, NN-8765, NNC-0141-0000-0100, NNC-141-01000, monolizumab,anti-NKG2A, humZ270, CAS: 1228763-95-8;[Species reactivity]:Human;[Target]:KLRC1, NKG2-A/NKG2-B type II integral membrane protein, NKG2-A/B-activating NK receptor, CD159